FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2243390646> ?p ?o ?g. }

• W2243390646 endingPage "185" @default.
• W2243390646 startingPage "175" @default.
• W2243390646 abstract "The available pharmacotherapy for patients with epilepsy primarily address the symptoms and are ineffective in about 40% of patients. Brain inflammation gained support as potential target for developing new therapies, especially the P2X7 receptor (P2X7R), involved in processing of IL-1β, might be an interesting candidate. This study was designed to investigate the effect of a novel P2X7R antagonist on the severity and on the number of chronic spontaneous recurrent seizures (SRS), which was unexplored until now.After one-week of vehicle treatment (20% HP-β-cyclodextrin), JNJ-42253432 was administered subcutaneously for another week under continuous video-electroencephalography monitoring (n = 17) in Sprague Dawley rats 3 months after kainic acid-induced status epilepticus. The proportion of different seizure classes, as well as the number of SRS/day were calculated for the vehicle and treatment period. In addition, post-mortem microglial activation and astrogliosis were assessed.A significant decrease of the proportion of type 4-5 SRS (p < 0.05), while an increase of type 1-3 was demonstrated (p < 0.05) from the vehicle to the treatment period. There was no effect of the P2X7R antagonist on the number of SRS/day or the glial markers.The P2X7R antagonist gave rise to a less severe profile of the chronic seizure burden without suppressing the SRS frequency. More studies are needed to unravel the underlying mechanisms of the beneficial effect on seizure severity and whether the administration of the compound during early epileptogenesis could induce long-term disease-modifying effects." @default.
• W2243390646 created "2016-06-24" @default.
• W2243390646 creator A5002877795 @default.
• W2243390646 creator A5009246872 @default.
• W2243390646 creator A5021024474 @default.
• W2243390646 creator A5026960157 @default.
• W2243390646 creator A5033203914 @default.
• W2243390646 creator A5054710911 @default.
• W2243390646 creator A5060931543 @default.
• W2243390646 creator A5063933960 @default.
• W2243390646 creator A5068334502 @default.
• W2243390646 creator A5072483856 @default.
• W2243390646 creator A5078766169 @default.
• W2243390646 creator A5085805590 @default.
• W2243390646 date "2016-06-01" @default.
• W2243390646 modified "2023-09-28" @default.
• W2243390646 title "P2X7 receptor antagonism reduces the severity of spontaneous seizures in a chronic model of temporal lobe epilepsy" @default.
• W2243390646 cites W1574063361 @default.
• W2243390646 cites W1642784876 @default.
• W2243390646 cites W1705576088 @default.
• W2243390646 cites W1928623436 @default.
• W2243390646 cites W1966126241 @default.
• W2243390646 cites W1968420305 @default.
• W2243390646 cites W1974809694 @default.
• W2243390646 cites W1984505770 @default.
• W2243390646 cites W1985129969 @default.
• W2243390646 cites W1993093440 @default.
• W2243390646 cites W2000134238 @default.
• W2243390646 cites W2000828660 @default.
• W2243390646 cites W2001739084 @default.
• W2243390646 cites W2001879021 @default.
• W2243390646 cites W2006716160 @default.
• W2243390646 cites W2010240177 @default.
• W2243390646 cites W2011085253 @default.
• W2243390646 cites W2013458002 @default.
• W2243390646 cites W2017055595 @default.
• W2243390646 cites W2022671065 @default.
• W2243390646 cites W2022981588 @default.
• W2243390646 cites W2026183163 @default.
• W2243390646 cites W2030029215 @default.
• W2243390646 cites W2037173759 @default.
• W2243390646 cites W2050190749 @default.
• W2243390646 cites W2056002632 @default.
• W2243390646 cites W2057230367 @default.
• W2243390646 cites W2060189028 @default.
• W2243390646 cites W2066564803 @default.
• W2243390646 cites W2079901569 @default.
• W2243390646 cites W2080823871 @default.
• W2243390646 cites W2082025704 @default.
• W2243390646 cites W2082858741 @default.
• W2243390646 cites W2083979012 @default.
• W2243390646 cites W2084383502 @default.
• W2243390646 cites W2087982685 @default.
• W2243390646 cites W2088581643 @default.
• W2243390646 cites W2103946141 @default.
• W2243390646 cites W2106643106 @default.
• W2243390646 cites W2110877402 @default.
• W2243390646 cites W2114570899 @default.
• W2243390646 cites W2120778240 @default.
• W2243390646 cites W2125389067 @default.
• W2243390646 cites W2128767149 @default.
• W2243390646 cites W2134209166 @default.
• W2243390646 cites W2136444917 @default.
• W2243390646 cites W2139080892 @default.
• W2243390646 cites W2143689643 @default.
• W2243390646 cites W2154276106 @default.
• W2243390646 cites W2167121498 @default.
• W2243390646 cites W2192584681 @default.
• W2243390646 doi "https://doi.org/10.1016/j.neuropharm.2016.01.018" @default.
• W2243390646 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26775823" @default.
• W2243390646 hasPublicationYear "2016" @default.
• W2243390646 type Work @default.
• W2243390646 sameAs 2243390646 @default.
• W2243390646 citedByCount "52" @default.
• W2243390646 countsByYear W22433906462016 @default.
• W2243390646 countsByYear W22433906462017 @default.
• W2243390646 countsByYear W22433906462018 @default.
• W2243390646 countsByYear W22433906462019 @default.
• W2243390646 countsByYear W22433906462020 @default.
• W2243390646 countsByYear W22433906462021 @default.
• W2243390646 countsByYear W22433906462022 @default.
• W2243390646 countsByYear W22433906462023 @default.
• W2243390646 crossrefType "journal-article" @default.
• W2243390646 hasAuthorship W2243390646A5002877795 @default.
• W2243390646 hasAuthorship W2243390646A5009246872 @default.
• W2243390646 hasAuthorship W2243390646A5021024474 @default.
• W2243390646 hasAuthorship W2243390646A5026960157 @default.
• W2243390646 hasAuthorship W2243390646A5033203914 @default.
• W2243390646 hasAuthorship W2243390646A5054710911 @default.
• W2243390646 hasAuthorship W2243390646A5060931543 @default.
• W2243390646 hasAuthorship W2243390646A5063933960 @default.
• W2243390646 hasAuthorship W2243390646A5068334502 @default.
• W2243390646 hasAuthorship W2243390646A5072483856 @default.
• W2243390646 hasAuthorship W2243390646A5078766169 @default.
• W2243390646 hasAuthorship W2243390646A5085805590 @default.
• W2243390646 hasConcept C118552586 @default.
• W2243390646 hasConcept C126322002 @default.
• W2243390646 hasConcept C170493617 @default.

• next